Eli Lilly & Co. (LLY) Tops Q1 EPS by $1.58, Beats on Revenue; Offers Strong Guidance
Get Alerts LLY Hot Sheet
Price: $1,180.16 -2.25%
Financial Fact:
Acquired in-process research and development: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Acquired in-process research and development: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $8.55, $1.58 better than the analyst estimate of $6.97. Revenue for the quarter came in at $19.8 billion versus the consensus estimate of $17.6 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2026 EPS of $35.50-$37.00, versus the consensus of $34.53. Eli Lilly & Co. sees FY2026 revenue of $82-85 billion, versus the consensus of $81.67 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Reading (RDI) Tops Q2 EPS by 4c
- Full Circle Lithium closes $5.14M private placement
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share